Focal segmental glomerulosclerosis 1 is a rare kidney condition that damages the kidney’s filtering units and can lead to protein leaking into the urine. Early signs of Focal segmental glomerulosclerosis 1 often include swelling in the legs or around the eyes, foamy urine, and sometimes high blood pressure. It is often recognized in childhood or early adulthood, and it usually follows a long-term course, although not everyone will have the same experience. Treatment aims to slow kidney damage and reduce protein loss, often with blood pressure medicines, careful salt control, and other supportive kidney care. Some people living with Focal segmental glomerulosclerosis 1 keep stable kidney function for years, while others may progress to kidney failure, which can be life-threatening without dialysis or a kidney transplant.
How many people live with Focal segmental glomerulosclerosis 1?
No reliable direct worldwide or U.S. count has been published for focal segmental glomerulosclerosis 1, which is a very rare inherited form of the broader kidney condition called focal segmental glomerulosclerosis. For focal segmental glomerulosclerosis overall, Orphanet places the number in the 1 to 9 per 100,000 range, which works out to roughly 80,000 to 740,000 people worldwide (Orphanet, 2024; United Nations, 2024) and about 3,000 to 30,000 people in the United States (Orphanet, 2024; U.S. Census Bureau, 2024), but focal segmental glomerulosclerosis 1 is only a small subset of these cases, so any condition-specific figure would be only a rough estimate rather than a direct count.
Overview
Focal segmental glomerulosclerosis 1Symptoms
Focal segmental glomerulosclerosis 1 often causes protein in the urine, swelling in the legs or around the eyes, and sometimes high blood pressure. Early signs of focal segmental glomerulosclerosis 1 can also include foamy urine and reduced kidney function.
Outlook and prognosis
With focal segmental glomerulosclerosis 1, outlook varies widely. Some people keep stable kidney function for years, while others develop worsening protein loss, swelling, and chronic kidney disease. Early treatment and close follow-up can slow damage and lower the risk of kidney failure.
Causes and risk factors
Focal segmental glomerulosclerosis 1 is caused by a disease-causing gene change, often inherited in families, though it can start new in one person. Blood pressure, infections, extra body weight, and other kidney stresses may worsen kidney damage or speed progression.
Genetic influences
Genetics can be very important in focal segmental glomerulosclerosis 1, especially when it starts in childhood or runs in families. Some gene changes raise risk, influence severity, and may help guide testing, treatment choices, and family counseling.
Diagnosis
Diagnosis of Focal segmental glomerulosclerosis 1 usually starts with urine and blood tests, then a kidney biopsy. Doctors also look at clinical features and family history. Genetic tests can help confirm the diagnosis of Focal segmental glomerulosclerosis 1.
Treatment and drugs
Treatment for focal segmental glomerulosclerosis 1 aims to protect kidney function and reduce protein leaking into the urine. Many need blood pressure medicines, salt restriction, diuretics, and sometimes steroids or other immune-calming drugs; advanced kidney failure may require dialysis or transplant.
Symptoms
Many people living with focal segmental glomerulosclerosis 1 feel well at first, so the first clue may come from a routine urine or blood test rather than something you can feel. One of the early features of focal segmental glomerulosclerosis 1 is protein leaking into the urine, which can later lead to swelling and higher blood pressure. Features vary from person to person and can change over time. As kidney damage builds, everyday energy and fluid balance can be affected more noticeably.
Protein leaking into the urine is often the earliest sign, and it can make urine look foamy or bubbly. In focal segmental glomerulosclerosis 1, this may be found on a routine urine test before you feel unwell. Heavy leakage can also lower blood protein and raise cholesterol on blood tests.
Extra fluid can collect around the eyes, ankles, feet, or lower legs. Shoes or rings may feel tighter, and body weight may go up because of fluid rather than body fat.
Blood pressure can rise as the kidneys become stressed. Many people do not feel this directly, so it may only be noticed when it is checked at home or in clinic.
Over time, the kidneys may filter waste less well, and blood tests may show a rising creatinine level or falling kidney function. As focal segmental glomerulosclerosis 1 advances, some may find they tire more easily, lose appetite, or feel sick to their stomach.
How people usually first notice Focal segmental glomerulosclerosis 1?
Many people first notice focal segmental glomerulosclerosis 1 when swelling starts around the eyes, ankles, feet, or belly because the kidneys are leaking protein instead of holding it in the blood where it belongs. Others learn something is wrong after a routine urine test shows protein, or after high blood pressure, foamy urine, or unexplained fatigue begins to show up. Because the first signs of focal segmental glomerulosclerosis 1 can be subtle at first, these early changes are often what lead to the kidney tests that uncover the condition.
Types of Focal segmental glomerulosclerosis 1
No distinct types of focal segmental glomerulosclerosis 1 are widely recognized.
Can I slow down the onset of symptoms?
For focal segmental glomerulosclerosis 1, there is no proven way to use lifestyle changes or medicine to reliably delay when symptoms begin. Research has not shown that diet, exercise, or supplements can prevent this inherited kidney condition, but keeping blood pressure under good control, avoiding smoking and medicines that can harm the kidneys, and having regular urine, blood pressure, and kidney function checks may help reduce extra strain on the kidneys and catch problems early. These steps may support kidney health, but they cannot promise that symptoms will be delayed or prevented.
What genetics can tell you about symptoms
Yes. In focal segmental glomerulosclerosis 1, changes in the ACTN4 gene are known to affect the kidney’s filtering cells, and this can influence when kidney problems start and how quickly protein leakage in the urine, swelling, high blood pressure, and loss of kidney function become more severe. Even within the same family, symptoms can vary, so genetics can give clues about risk and likely disease course, but they usually cannot predict exactly which symptoms each person will have or how fast they will progress.
Causes and risk factors
Many living with focal segmental glomerulosclerosis 1 develop kidney problems because of a change in the ACTN4 gene. This change can be passed down in a family, and some people have it as a new gene change. Having a gene change doesn't mean you'll definitely develop the condition. High blood pressure, higher body weight, smoking, and some medicines can add stress to the kidneys. These factors may affect the early symptoms of focal segmental glomerulosclerosis 1 and how fast it gets worse.
What are the most common causes or risk factors?
For focal segmental glomerulosclerosis 1, the main cause is an inherited change in a gene called ACTN4, which affects the tiny filters in the kidneys and can lead to scarring over time. The biggest risk factor is having a parent or other close family member with the condition or the same gene change. Unlike some other kinds of kidney scarring, there are no well-proven lifestyle or environmental risk factors known to directly cause this specific genetic type.
Environmental and biological risk factors
For focal segmental glomerulosclerosis 1, the list of known risk factors is fairly short. Some risks are carried inside the body, others come from the world around us. In this form, clear outside exposures have not been shown to reliably raise the chance of it occurring. Most cases are tied to a body-based change present from the start, although it can appear for the first time in a family.
The main known biological risk is carrying the internal change linked to focal segmental glomerulosclerosis 1. When this change runs in a family, close relatives can have a higher chance of the condition.
Some people with focal segmental glomerulosclerosis 1 are the first known person in their family to have it. In those cases, the underlying change likely started newly around conception rather than being passed down.
No medicine, infection, toxin, or pregnancy exposure has been clearly proven to cause focal segmental glomerulosclerosis 1. This specific form is mainly driven by body-based factors rather than environmental ones.
Genetic risk factors
Focal segmental glomerulosclerosis 1 is caused by a harmful change in the ACTN4 gene, which helps support the kidney’s filtering cells. For many living with this form, the main inherited risk is having one altered copy of ACTN4, often passed through families in a dominant pattern. Carrying a genetic change doesn’t guarantee the condition will appear, and the genetic causes of focal segmental glomerulosclerosis 1 can affect family members differently.
ACTN4 changes: Harmful changes in ACTN4 cause focal segmental glomerulosclerosis 1. This gene helps the kidney’s filtering cells stay stable, so a change can make scarring more likely over time.
Dominant inheritance: This condition is usually passed down in an autosomal dominant pattern, which means one altered copy of ACTN4 can be enough to cause disease. If a parent carries the change, each child has a 1 in 2, or 50%, chance of inheriting it.
Family history: A family history of focal segmental glomerulosclerosis, long-term protein in the urine, or unexplained kidney failure raises the chance of an inherited form. Sometimes this pattern is easy to miss because relatives may become ill at different ages or to different degrees.
New mutation: Some people have a new ACTN4 change that happened for the first time in them and was not inherited from either parent. This means focal segmental glomerulosclerosis 1 can be genetic even when no one else in the family is known to have it.
Variable expression: Family members with the same ACTN4 change may not be affected in the same way. One relative may have early symptoms of focal segmental glomerulosclerosis 1, while another may not develop clear kidney problems until much later.
Lifestyle risk factors
Focal segmental glomerulosclerosis 1 is usually driven by an inherited change affecting the kidney’s filtering cells, so lifestyle habits do not cause it. Still, how lifestyle affects focal segmental glomerulosclerosis 1 can matter because daily habits may influence protein leakage, swelling, blood pressure control, and the speed of kidney function loss. The most helpful focus is on habits that reduce strain on the kidneys and support treatment goals.
A high-sodium diet can worsen fluid retention, raise blood pressure, and make swelling harder to control in focal segmental glomerulosclerosis 1. Lowering salt intake may improve response to diuretics and other kidney-protective treatment.
Very high protein intake can increase pressure inside the kidney filters and may raise protein loss in the urine. Protein should usually be balanced rather than excessive, with targets individualized by a kidney specialist or dietitian.
Excess body weight can add stress to the glomeruli and may accelerate kidney damage in people with focal segmental glomerulosclerosis 1. Maintaining a healthy weight can support blood pressure control and may reduce ongoing kidney strain.
Regular moderate exercise can help control blood pressure, body weight, and cardiovascular risk, which all affect kidney outcomes. Overtraining is not usually the goal, but consistent activity can support overall management of focal segmental glomerulosclerosis 1.
Risk prevention
For focal segmental glomerulosclerosis 1, true prevention of the condition itself is often not possible, especially when it is linked to an inherited risk. In day-to-day life, prevention usually means lowering the chance of kidney damage getting worse and reducing complications such as high blood pressure, fluid buildup, and protein loss in the urine. Prevention is about lowering risk, not eliminating it completely.
Keeping blood pressure in a healthy range is one of the most important ways to protect the kidneys in focal segmental glomerulosclerosis 1. Many people need regular checks and treatment, often with medicines that also lower protein leaking into the urine.
Some drugs can strain the kidneys, including frequent use of pain relievers like ibuprofen or naproxen. Before starting new prescription drugs, supplements, or contrast dye scans, it is wise to check that they are safe for someone living with focal segmental glomerulosclerosis 1.
Too much salt can worsen swelling and raise blood pressure, which puts extra stress on damaged kidneys. Choosing lower-salt foods and following your care team's advice about fluids can help reduce ankle swelling, puffiness around the eyes, and other early symptoms of focal segmental glomerulosclerosis 1 getting worse.
High blood sugar can add another layer of kidney injury over time. If you are at risk for diabetes, staying active, managing weight, and getting routine blood sugar checks may help protect kidney function.
Can you prevent Focal segmental glomerulosclerosis 1?
No, you usually cannot fully prevent focal segmental glomerulosclerosis 1, especially when it is linked to an inherited gene change. Even so, some people may be able to lower added stress on the kidneys by keeping blood pressure and blood sugar in a healthy range, not smoking, and avoiding medicines that can harm the kidneys unless a doctor says they are safe. These steps cannot guarantee prevention, but they may help protect kidney function.
Transmission
Focal segmental glomerulosclerosis 1 is not infectious, so it cannot be passed from one person to another through contact, kissing, sex, blood, food, or the air. In this condition, the main issue is inheritance: focal segmental glomerulosclerosis 1 is usually passed down in an autosomal dominant pattern, which means a parent with the gene change can pass it to a child.
For many families asking about how focal segmental glomerulosclerosis 1 is inherited, this means each child has a 1 in 2, or 50%, chance of inheriting the altered gene. Sometimes the gene change starts for the first time in one person, called a new mutation, so there may be no earlier family history.
When to test your genes
Genetic testing is most useful if focal segmental glomerulosclerosis begins in childhood or early adulthood, runs in your family, does not improve with standard steroid treatment, or appears before a kidney transplant evaluation. Results can clarify cause, guide treatment choices, and help estimate recurrence risk after transplant.
Diagnosis
Focal segmental glomerulosclerosis 1 is often suspected when routine urine or blood tests show kidney strain, especially in someone with swelling in the legs, foamy urine, or rising blood pressure. Doctors usually begin by looking for signs that the kidneys are leaking protein and not filtering as well as they should. Because several kidney conditions can look similar at first, the diagnosis of focal segmental glomerulosclerosis 1 usually involves combining symptoms, lab results, and one or more confirmatory tests.
Urine tests check for protein leaking from the kidneys, and sometimes blood in the urine as well. A large amount of protein in the urine is one of the main clues that leads doctors to consider focal segmental glomerulosclerosis 1.
Blood tests measure kidney function, including creatinine and albumin levels, and can show how much the kidneys are being affected. Other lab tests may help rule out common conditions that can also cause protein loss or kidney damage.
A kidney biopsy is often the key test because it lets doctors examine a tiny sample of kidney tissue under a microscope. In focal segmental glomerulosclerosis 1, the biopsy may show scarring in parts of some filtering units, which helps confirm the diagnosis and rule out other kidney diseases.
Because focal segmental glomerulosclerosis 1 is a genetic form of kidney disease, genetic tests may be used to look for an inherited cause. This can help explain why the condition developed, guide treatment choices, and show whether family members may also want counseling or testing.
How is Focal segmental glomerulosclerosis 1 diagnosed?
Doctors usually suspect focal segmental glomerulosclerosis after urine tests show a lot of protein leaking into the urine and blood tests check how well the kidneys are working. The diagnosis is most often confirmed with a kidney biopsy, which means taking a tiny sample of kidney tissue and looking for patchy scarring in some of the kidney’s filters under a microscope. If it starts at a younger age, runs in the family, or the biopsy suggests an inherited cause, genetic testing may be used to look for a gene change linked to this type.
Stages of Focal segmental glomerulosclerosis 1
Focal segmental glomerulosclerosis 1 does not have defined progression stages. This is because it is usually tracked by how much kidney damage or protein leakage is present over time, rather than by a fixed set of step-by-step stages that everyone moves through in the same way. Doctors usually start with a conversation about swelling, foamy urine, blood pressure, and other early symptoms of focal segmental glomerulosclerosis, then check urine and blood tests to see how well the kidneys are working. Monitoring often includes repeat urine protein tests, kidney function blood tests, blood pressure checks, and sometimes genetic testing or a kidney biopsy to confirm the cause.
Outlook and prognosis
The outlook for focal segmental glomerulosclerosis 1 is variable, but many affected people develop persistent proteinuria and gradually worsening kidney function over time. In the classic genetic form, which is often linked to NPHS2-related disease, steroid resistance is common, so remission is less likely with standard immunosuppressive treatment than in some non-genetic forms of FSGS. A substantial proportion progress to chronic kidney disease and eventually end-stage kidney disease, sometimes in childhood but often later depending on the specific variant and severity at presentation. Prognosis is generally better when blood pressure and proteinuria are well controlled and complications such as edema, infections, and thrombosis are prevented. For those who need a kidney transplant, recurrence in the transplanted kidney is usually less common in genetic FSGS than in primary idiopathic FSGS, which can improve long-term graft outlook. Mortality is driven mainly by complications of advanced kidney failure and by increased cardiovascular risk rather than by the kidney disorder itself in isolation.
Long-term effects
For many people, the long-term effects of focal segmental glomerulosclerosis 1 center on how well the kidneys keep working over time. Some may stay fairly stable for years, while others develop a steady loss of kidney function. Long-term effects vary widely, and early symptoms of focal segmental glomerulosclerosis 1 do not always predict what the course will be like. When kidney damage builds up, it can affect energy, fluid balance, blood pressure, and overall health.
The main long-term effect is a gradual drop in kidney function, which can happen over months or years. In some people this remains mild, but in others it progresses to chronic kidney disease or kidney failure.
Ongoing leakage of protein into the urine can continue for a long time and may be hard to fully stop. This can lead to low blood protein levels, swelling, and a higher chance of complications linked to nephrotic syndrome.
Fluid buildup can become a lasting issue, especially in the legs, ankles, around the eyes, or belly. Many living with focal segmental glomerulosclerosis 1 find that swelling tends to flare when kidney function worsens or urine protein stays high.
High blood pressure is common over the long term because damaged kidneys help regulate pressure less effectively. If it remains uncontrolled, it can further strain the kidneys, heart, and blood vessels.
How is it to live with Focal segmental glomerulosclerosis 1?
Living with focal segmental glomerulosclerosis 1 often means keeping a close eye on swelling, tiredness, foamy urine, and blood pressure, while also managing frequent lab checks, medications, and sometimes limits on salt and fluid. For many people, day-to-day life can feel unpredictable because kidney function may stay stable for a time or gradually worsen, which can affect school, work, exercise, and travel planning. It also touches the people around you: family members may help with appointments, meals, and emotional support, and because this form can run in families, relatives may also face questions about their own kidney health and whether genetic counseling would be helpful.
Treatment and drugs
Treatment for focal segmental glomerulosclerosis 1 aims to reduce protein leaking into the urine, protect kidney function, and slow worsening over time. Doctors often recommend a combination of lifestyle changes and drugs, such as blood pressure medicines that also lower protein loss, diuretics to help with swelling, and sometimes steroids or other immune-calming medicines if inflammation is thought to be driving the disease. Some people also need changes in salt intake, careful blood pressure control, and treatment for high cholesterol, since these steps can ease strain on the kidneys in day-to-day life. Not every treatment works the same way for every person, and because focal segmental glomerulosclerosis 1 can have a genetic cause, some medicines may help less than they do in other kidney conditions. If kidney damage becomes severe, treatment may include dialysis or a kidney transplant.
Can you cure Focal segmental glomerulosclerosis 1?
There is no cure for focal segmental glomerulosclerosis 1 right now. Treatment cannot remove the condition, but it can help protect the kidneys, lower the amount of protein leaking into the urine, control blood pressure, and ease swelling. For some people, kidney damage still gets worse over time, and dialysis or a kidney transplant may eventually be needed.
Non-drug treatment
Living with focal segmental glomerulosclerosis 1 often means dealing with swelling, tiredness, and the worry of protecting kidney function over time. Managing this condition often includes daily habits and supportive care that reduce strain on the kidneys and help control symptoms. These steps do not replace medical care, but they can make a real difference in how you feel and how well treatment works.
Cutting back on salt can help reduce swelling and lower blood pressure, which is important for people with focal segmental glomerulosclerosis 1. A low-salt diet for focal segmental glomerulosclerosis 1 often means limiting packaged foods, fast food, and salty snacks.
Some may find that eating a moderate amount of protein, rather than a very high-protein diet, helps avoid extra workload on the kidneys. A kidney dietitian can help you choose meals that still provide enough nutrition.
If swelling is a problem, your care team may suggest watching how much fluid you drink each day. This can be especially helpful when ankles feel tight by evening or rings no longer fit comfortably.
Regular movement and a healthy weight can support blood pressure, heart health, and overall kidney health. Simple routines like walking or gentle cycling can have lasting benefits when they fit your energy level.
Your genes may have an impact on how drugs work for you
For many people living with focal segmental glomerulosclerosis, inherited changes linked to the disease can affect how well common treatments work, especially medicines that calm down the immune system. In day-to-day life, this can mean one person’s protein in the urine improves with treatment, while another’s does not, because in some inherited forms the problem is built into the kidney’s filtering cells rather than caused mainly by inflammation. That is why genetic testing can sometimes help doctors choose treatments more wisely and avoid medicines that are less likely to help.
Pharmacological treatments
For many living with focal segmental glomerulosclerosis 1, treatment is aimed at lowering protein loss in the urine, protecting kidney function, and easing problems such as swelling or high blood pressure. Because this form is often linked to an inherited gene change, medicines do not usually correct the root cause, and some immune-suppressing drugs may help less than they do in other types of FSGS. Not everyone responds to the same medication in the same way. The best treatment for focal segmental glomerulosclerosis 1 often combines kidney-protective drugs with close follow-up and changes over time.
Drugs such as lisinopril, enalapril, and ramipril are often used to lower blood pressure and reduce protein leaking into the urine. This can slow kidney damage over time, even in people whose blood pressure is only mildly high.
Losartan, valsartan, and irbesartan work in a similar way to ACE inhibitors and are often used if an ACE inhibitor causes cough or is not tolerated. Doctors usually use one of these two groups, not both together, and monitor kidney function and potassium closely.
Water pills such as furosemide, torsemide, and bumetanide can help with swelling in the legs, around the eyes, or in the belly. They do not treat the kidney scarring itself, but they can make day-to-day comfort much better.
Prednisone or prednisolone may be tried in some people with FSGS, especially when doctors think the disease may respond to immune treatment. In inherited focal segmental glomerulosclerosis 1, steroids are often less effective, so the risks and benefits need careful review.
Genetic influences
Focal segmental glomerulosclerosis 1 is a rare inherited form of kidney scarring most often caused by a change in the ACTN4 gene. ACTN4 helps the kidney’s filtering cells keep their shape and strength, so when the gene is altered, those filters can become fragile and start leaking protein into the urine over time. This subtype is usually passed down in an autosomal dominant pattern, which means a parent with the gene change has a 1 in 2, or 50%, chance of passing it on to each child. Even within the same family, people with focal segmental glomerulosclerosis 1 can develop kidney problems at different ages and with different severity. To put these pieces together, doctors may suggest genetic counseling. Genetic testing can help confirm the diagnosis, show whether relatives may also be at risk, and sometimes guide decisions about kidney monitoring and family planning.
Is Focal segmental glomerulosclerosis 1 genetic?
Genetics can be very important in focal segmental glomerulosclerosis 1, especially when it starts in childhood or runs in families. Some gene changes raise risk, influence severity, and may help guide testing, treatment choices, and family counseling.
Having a genetic risk is not necessarily a diagnosis
It is normal for people to have genetic variants, and these are common across the general population. Most of them do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant connected with a condition indicates a possible association, not a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, though, one well-understood variant in a certain gene can by itself confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
Because Focal segmental glomerulosclerosis 1 is driven by an inherited change in a gene important for the kidney’s filtering cells, the genetic result can shape treatment choices early on. In many people with Focal segmental glomerulosclerosis 1, steroids and other immune-suppressing drugs are less likely to control protein leakage in the urine than they are in forms linked to immune-system injury, so long treatment courses may be less helpful. Beyond trial and error, genetics offers another way to decide whether to focus on kidney-protective care, such as blood pressure medicines that reduce protein loss in the urine, salt management, and close follow-up. For many living with Focal segmental glomerulosclerosis 1, the main value of genetic testing is often to show which treatments are worth trying, rather than to predict how fast the body will break down a specific drug. Genetic testing for Focal segmental glomerulosclerosis 1 can also help with family counseling and may suggest a lower chance of the disease returning after a kidney transplant than in some non-genetic forms. Doctors still combine the gene result with kidney function, blood pressure, age, and the amount of protein in the urine when planning care.
Interactions with other conditions
People living with focal segmental glomerulosclerosis 1 often deal with more than kidney-related issues, because ongoing protein loss in the urine and reduced kidney function can affect the rest of the body. For many, this can mean swelling gets worse if heart disease is also present, or blood pressure becomes harder to control when chronic kidney disease progresses. Another important aspect is how it may link with other diseases. Focal segmental glomerulosclerosis 1 can also raise the risk of complications such as blood clots, infections, and bone weakness, especially if kidney damage is advanced or treatment includes medicines that lower the immune system. Diabetes, obesity, and autoimmune diseases may make kidney injury harder to manage, and the early symptoms of focal segmental glomerulosclerosis can sometimes overlap with problems caused by these conditions. Interactions can look very different from person to person, so it is important to have regular follow-up that checks blood pressure, kidney function, cholesterol, and any other health problems that may be adding strain to the kidneys.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Focal segmental glomerulosclerosis 1?
Other kidney problems can look a lot like focal segmental glomerulosclerosis 1, especially conditions that make protein leak into the urine and cause swelling, such as minimal change disease, membranous nephropathy, and IgA nephropathy. Diabetic kidney disease and kidney inflammation linked to lupus can also cause similar signs, and in some people long-term high blood pressure may look similar too. Because these conditions can overlap so much, doctors often need urine and blood tests, and sometimes a small kidney tissue sample, to tell them apart.
History
Long before kidney biopsy became routine, doctors were trying to make sense of why some people developed protein leaking into the urine, swelling in the legs, and slowly worsening kidney function. What we now call focal segmental glomerulosclerosis 1, often shortened to FSGS, emerged from those efforts to describe a pattern of kidney injury rather than a single, simple disease. In everyday life, this could look like someone whose shoes suddenly feel tight from ankle swelling, or a child or adult whose urine seems unusually foamy.
As medical science evolved, pathologists began examining tiny samples of kidney tissue under the microscope and noticed a recurring pattern: scarring that affected only some of the kidney’s filtering units, and only parts of each affected filter. That observation shaped the name itself. “Focal” means some filters are involved, “segmental” means only part of an individual filter is scarred, and “glomerulosclerosis” refers to scarring in those filters. Over time, this helped doctors separate FSGS from other kidney conditions that can cause similar symptoms but look different on biopsy.
In the second half of the 20th century, researchers recognized that FSGS was not one uniform illness. Many living with FSGS had different triggers, ages at onset, and speeds of progression, which led to a better understanding that the same biopsy pattern can arise from more than one underlying cause. Some cases appeared after reduced kidney mass, obesity, infections, or certain medicines, while others seemed to reflect a problem present within the kidney filter itself from the start.
More recently, advances in genetics and kidney biology have added another layer to that history. Researchers later identified a genetic cause for some forms of FSGS, including what is categorized as focal segmental glomerulosclerosis 1, helping explain why kidney disease can run in some families and why the condition can behave differently from one person to another. Knowing this history also helps make sense of modern care: today, doctors often combine symptoms, urine and blood tests, biopsy findings, and family history to understand the type of FSGS and guide treatment.